02/10/2026
GRMC is proud to announce we successfully treated our first patient using the Symplicity Spyral™ renal denervation procedure, an FDA-approved option for certain patients with hard-to-control high blood pressure, on December 31st 2025.
This minimally invasive procedure targets overactive kidney nerves, requires no permanent implant, and can help lower blood pressure and reduce the risk of serious complications.
We’re proud to bring this advanced heart care to Seguin and the surrounding communities, combining leading technology with compassionate, patient-centered care.
https://bit.ly/4pR5tYZ
GRMC is proud to announce that we have successfully treated our first patient using the new Symplicity Spyral™ renal denervation (RDN) procedure.